The Europe advanced wound care market is projected to register a substantial CAGR during the forecast period, between 2021 and 2028. Advanced wound care products are used to treat chronic or acute wounds. Advanced wound care solutions function by managing appropriate oxygen flow and maintaining the required wound temperature. Advanced wound care treatments, such as foam and film dressings, hydrocolloids, hydrogels, and alginates, maintain the wound wet for healing while without occluding it. Furthermore, it protects against microbial and bacterial infection, decreasing the problems.
Market Trends, Drivers, Restraints, and Opportunities
- Increasing incidence of diabetes, poor lifestyle, and an elderly population are major factors driving the Europe advanced wound care market.
- Rising occurrence rate of infected wounds is one of the primary factors driving the advanced wound care market in Europe.
- Government efforts, technology advancements and pressing requirement for safer and faster treatment of chronic wounds are major factors driving the market growth.
- High cost of therapy is a major barrier that can hinder the market growth across Europe.
- Rising demand for active wound care products, particularly in emerging markets, is likely to generate a variety of growth opportunities in the market.
Scope of Advanced Wound Care Market Report
The report on the Europe Advanced Wound Care market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
Europe Advanced Wound Care Market – Industry Analysis, Size, Share, Growth, Trends, and Forecast
2018 & 2019
Types (Active Wound Care [Growth Factors and Skin Substitutes], Wound Dressings [Antimicrobial Dressings, Alginate Dressings, Composites, Foam Dressings, Film Dressings, Hydrocolloids Collagen, Hydrogels, and Gauze], Therapy Devices [Compression Therapy, Hyperbaric Oxygen Equipment, Negative Pressure Wound Therapy, Pressure Relief Devices, Other Therapy Devices], and Other Advance Wound Care Types), Applications (Chronic Wound [Arterial & Venous Ulcer, Diabetic Foot Ulcer, Pressure Ulcer, and Other Chronic Wounds], and Acute Wound [Burns, Surgical Wounds, and Other Acute Wounds]), End-users (Outpatient Facilities and Inpatient Facilities)
Germany, Italy, The UK, Spain, France, and The Rest of Europe
Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast
Europe Advanced Wound Care Market Segment Insights
Wound dressings segment is projected to hold significant market share
Based on types, the market can be fragmented into active wound care, wound dressings, therapy devices, and other advance wound care types. The active wound care segment can be bifurcated into growth factors and skin substitutes. The wound dressings segment can be further classified as antimicrobial dressings, alginate dressings, composites, foam dressings, film dressings, hydrocolloids collagen, hydrogels, and gauze. Additionally, the therapy devices segment can be segmented into compression therapy, hyperbaric oxygen equipment, negative pressure wound therapy, pressure relief devices, and other therapy devices. The wound dressings segment is projected to a hold significant market share due to rising spending on chronic and surgical wounds, an increase in the number of burn injuries, and technical breakthroughs in dressings. The introduction of new devices and developments in product technology is expected to drive the segment growth.
Chronic wound segment segment is anticipated to account for a substantial share
On the basis of applications, the market can be bifurcated into chronic wound and acute wound. The chronic wound segment can segmented into arterial & venous ulcer, diabetic foot ulcer, pressure ulcer, and other chronic wounds. Furthermore, the acute wound segment can be divided into burns, surgical wounds, and other acute wounds. The chronic wound segment is anticipated to account for a substantial share owing to an expanding patient population suffering from diabetic foot ulcers, pressure ulcers, and other illnesses, as well as an increase in the cost of treating these conditions.
Inpatient facilities segment to register a rapid pace during the forecast period
In terms of end-users, the Europe advanced wound care market can be segregated into outpatient facilities and inpatient facilities. The inpatient facilities segment is estimated to register a rapid pace during the forecast period. An expansion in multispecialty hospitals with wound management sections, particularly in developing nations. The high volume of treatment operations performed in hospitals as well as the availability of reimbursements are driving the expansion of this segment.
Germany is expected to dominate the market
In terms of region, the market can be categorized as Germany, Italy, the UK, Spain, France, and the Rest of Europe. Germany is expected to dominate the market. The market is anticipated to fuel by sophisticated technologies, increasing government expenditures, and investments in wound care research. Furthermore, rising demand for active wound care products and the treatment associated with them, particularly in emerging markets, is expected to provide better prospects for the Germany advanced wound care market.
- Active Wound Care
- Growth Factors
- Skin Substitutes
- Wound Dressings
- Antimicrobial Dressings
- Alginate Dressings
- Foam Dressings
- Film Dressings
- Hydrocolloids Collagen
- Therapy Devices
- Compression Therapy
- Hyperbaric Oxygen Equipment
- Negative Pressure Wound Therapy
- Pressure Relief Devices
- Other Therapy Devices
- Other Advance Wound Care types
- Chronic Wound
- Arterial & Venous Ulcer
- Diabetic Foot Ulcer
- Pressure Ulcer
- Other Chronic Wounds
- Acute Wound
- Surgical Wounds
- Other Acute Wounds
- Outpatient Facilities
- Inpatient Facilities
- The UK
- Rest of Europe
Key players in the Europe Advanced Wound Care market are Smith and Nephew, PLC, Coloplast Group, Molyncke Health Care, Convatec, Inc., Integra Life Sciences Corporation, Medline Industries, Inc., Organogenesis, Inc., Mimedx Group, Inc., Laboratories Urgo, and Systagenix. These players have widely engaged in several market development activities including collaborations, agreements, mergers & acquisitions, production capacity expansion, new product launches, and partnerships to increase their market share.